Information  X 
Enter a valid email address

Company Name matching 'Sequana Medical'

Date
Time Source
Company
Announcement
23 Apr 2019 5:00 pm GNW     Sequana Medical NV Sequana Medical announces Annual General Meeting of Shareholders on 23 May 2019
04 Apr 2019 6:00 am GNW     Sequana Medical NV Sequana Medical announces 2018 Full Year Results and 2019 Outlook
28 Mar 2019 6:00 am GNW     Sequana Medical NV Sequana Medical Notice of 2018 Full Year Results and 2019 Outlook
26 Mar 2019 6:00 pm GNW     Sequana Medical NV Extraordinary General Shareholders' Meeting to be held on 25 April 2019
18 Mar 2019 4:30 pm GNW     Sequana Medical Sequana Medical announces the end of the stabilisation period of its offering
01 Mar 2019 6:00 am GNW     Sequana Medical Sequana Medical: Mid-Stabilisation Period Announcement
25 Feb 2019 6:00 am GNW     Sequana Medical Sequana Medical: Transparency Notifications from Shareholders
20 Feb 2019 6:25 am GNW     Sequana Medical Sequana Medical: Mid-Stabilisation Period Announcement
18 Feb 2019 6:00 am GNW     Sequana Medical Sequana Medical NV: Disclosure of Outstanding Voting Securities
08 Feb 2019 5:32 pm GNW     Sequana Medical Sequana Medical raises €27.5 million in successful Initial Public Offering
07 Feb 2019 2:25 pm GNW     Sequana Medical Sequana Medical announces the Coverage of the Base Offering of Its Initial Public Offering on Euronext Brussels
31 Jan 2019 6:00 am GNW     Sequana Medical Sequana Medical Launches Its Initial Public Offering on Euronext Brussels
29 Jan 2019 6:00 am GNW     Sequana Medical Sequana Medical receives Breakthrough Device designation from the FDA for its alfapump®
30 Nov 2018 6:00 am GNW     Sequana Medical Sequana Medical NV: Update regarding the Launch of an Initial Public Offering on Euronext Brussels
15 Nov 2018 6:00 am GNW     Sequana Medical Sequana Medical NV: UK NICE recommends use of the alfapump® for the treatment of refractory ascites caused by cirrhosis under special arrangements
08 Nov 2018 6:02 am GNW     Sequana Medical Sequana Medical Announces the Appointments of Industry Experts Pierre Chauvineau as Chairman and Wim Ottevaere as Non-Executive Director
  6:00 am GNW     Sequana Medical Sequana Medical Announces Intention to Launch an Initial Public Offering on Euronext Brussels
15 Oct 2018 6:00 am GNW     Sequana Medical Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises €8.5 million from leading Belgian investors including Newton Biocapital, PMV and SFPI-FPIM as well as existing shareholders
17 Sep 2018 6:05 am GNW     Sequana Medical Sequana Medical presents pre-clinical proof of concept results of its Direct Sodium Removal (DSR) therapy for the management of volume overload in heart failure at the Annual Scientific Meeting of the Heart Failure Society
  6:00 am GNW     Sequana Medical Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t